Casdin Capital

Latest statistics and disclosures from Casdin Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Casdin Capital

Companies in the Casdin Capital portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Invitae (NVTA) 8.6 $347M 12M 28.43
Biolife Solutions Com New (BLFS) 8.0 $320M 7.6M 42.32
EXACT Sciences Corporation (EXAS) 5.6 $225M 2.4M 95.45
Pacific Biosciences of California (PACB) 5.1 $204M +59% 8.0M 25.55
Fate Therapeutics (FATE) 5.0 $202M 3.4M 59.27
Alnylam Pharmaceuticals (ALNY) 4.7 $189M 1.0M 188.81
Maxcyte (MXCT) 4.2 $171M NEW 14M 12.21
Blueprint Medicines (BPMC) 4.0 $159M 1.6M 102.81
Somalogic Class A Com (SLGC) 3.8 $154M NEW 12M 12.39
Verve Therapeutics (VERV) 3.6 $143M 3.0M 47.00
Relay Therapeutics (RLAY) 2.9 $116M +8% 3.7M 31.53
Twist Bioscience Corp (TWST) 2.7 $107M 1.0M 106.97
Sarepta Therapeutics (SRPT) 2.5 $102M +24% 1.1M 92.48
Codexis (CDXS) 2.5 $101M 4.3M 23.26
Agios Pharmaceuticals (AGIO) 2.5 $100M 2.2M 46.15
Absci Corp (ABSI) 2.2 $90M NEW 7.7M 11.63
Denali Therapeutics (DNLI) 2.1 $86M +5% 1.7M 50.45
Ginkgo Bioworks Holdings Cl A Shs (DNA) 2.1 $84M NEW 7.2M 11.59
Century Therapeutics (IPSC) 2.0 $81M 3.2M 25.16
Revolution Medicines (RVMD) 1.9 $77M +21% 2.8M 27.51
Caredx (CDNA) 1.9 $76M 1.2M 63.37
Tenaya Therapeutics (TNYA) 1.8 $74M NEW 3.6M 20.65
Beam Therapeutics (BEAM) 1.8 $71M 819k 87.01
Tango Therapeutics (TNGX) 1.8 $71M NEW 5.5M 12.93
Dermtech Ord ord (DMTK) 1.4 $56M 1.7M 32.11
Beigene Sponsored Adr (BGNE) 1.4 $55M 150k 363.00
Allogene Therapeutics (ALLO) 1.3 $54M +71% 2.1M 25.70
Global Blood Therapeutics In (GBT) 1.2 $49M +46% 1.9M 25.48
Adaptive Biotechnologies Cor (ADPT) 1.2 $49M 1.4M 33.99
Sema4 Holdings Corp Com Cl A (SMFR) 0.9 $38M NEW 5.0M 7.59
Alector (ALEC) 0.9 $38M 1.7M 22.82
Generation Bio (GBIO) 0.8 $33M -17% 1.3M 25.07
Singular Genomics Systems In (OMIC) 0.8 $30M 2.7M 11.19
4d Molecular Therapeutics In (FDMT) 0.7 $30M 1.1M 26.97
Crispr Therapeutics Namen Akt (CRSP) 0.7 $30M 266k 111.93
Magenta Therapeutics (MGTA) 0.7 $28M +16% 3.9M 7.28
Syndax Pharmaceuticals (SNDX) 0.6 $23M 1.2M 19.11
Monte Rosa Therapeutics (GLUE) 0.5 $21M 961k 22.28
Zai Lab Adr (ZLAB) 0.5 $20M 190k 105.39
23andme Holding Class A Com (ME) 0.4 $17M -32% 1.8M 9.06
908 Devices (MASS) 0.3 $13M 407k 32.52
Recursion Pharmaceuticals In Cl A (RXRX) 0.3 $13M 548k 23.01
Oric Pharmaceuticals (ORIC) 0.3 $13M 602k 20.91
Kronos Bio (KRON) 0.3 $12M 583k 20.96
Vertex Pharmaceuticals Incorporated Call Option (VRTX) 0.2 $9.1M NEW 50k 181.40
Decibel Therapeutics (DBTX) 0.2 $9.0M 1.2M 7.71
Alpha Teknova (TKNO) 0.2 $7.5M 300k 24.89
Orchard Therapeutics Ads (ORTX) 0.1 $5.9M -19% 2.6M 2.30
Seer Com Cl A (SEER) 0.1 $5.2M 150k 34.53
Berkeley Lts (BLI) 0.1 $3.9M 200k 19.56
Stoke Therapeutics (STOK) 0.1 $3.1M 120k 25.44
Foghorn Therapeutics (FHTX) 0.1 $3.0M 215k 13.93
Nautilus Biotechnology (NAUT) 0.0 $1.4M -55% 225k 6.14
Sana Biotechnology (SANA) 0.0 $1.4M 60k 22.52

Past Filings by Casdin Capital

SEC 13F filings are viewable for Casdin Capital going back to 2015

View all past filings